News
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
10d
MedPage Today on MSNCDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV ShotWith the CDC director's chair still empty, HHS Secretary Robert F. Kennedy Jr. endorsed recommendations made months ago by ...
The Centers for Disease Control and Prevention's vaccine advisory committee wrapped up the first day of its meeting since Health and Human Services Secretary Robert F. Kennedy Jr. dismissed the entire ...
8d
Zacks Investment Research on MSNMRNA Stock Jumps on CDC's Revised RSV Vaccine RecommendationsShares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the ...
Earlier this year, a group of vaccine experts on the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to expand RSV vaccination to high-risk adults starting at age 50.
Adults as young as 50 may now qualify for an RSV vaccine if they have certain health conditions, according to a quiet update from the U.S. Centers for Disease Control and Prevention (CDC).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results